Viewing Study NCT01514734


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-01-03 @ 8:16 PM
Study NCT ID: NCT01514734
Status: TERMINATED
Last Update Posted: 2013-10-21
First Post: 2012-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
Sponsor: Alcon Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary open-angle glaucoma View
None Ocular hypertension View
None Pigment dispersion glaucoma View